DCF — GREAT PLAINS HEALTH
Enterprise Value: $55.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$55.9M
Enterprise Value
$9.5M
PV of Cash Flows
$46.4M
PV of Terminal Value
$74.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $276.9M | $12.2M | 4.0% | $-0.9M | $-0.8M |
| Year 2 | $285.2M | $15.4M | 5.0% | $1.3M | $1.0M |
| Year 3 | $293.8M | $18.8M | 6.0% | $3.5M | $2.6M |
| Year 4 | $302.6M | $20.9M | 7.0% | $4.7M | $3.2M |
| Year 5 | $311.7M | $22.3M | 7.0% | $5.5M | $3.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $55.9M. Terminal value accounts for 83% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$268.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03898194009553329
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5